ContraVir Pharmaceuticals, Inc.
ContraVir Pharmaceuticals, Inc. (CTRV) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 17 transactions totaling $34.7K, demonstrating a bullish sentiment with $34.7K in net insider flow. The most recent transaction on Jan 3, 2018 involved a transaction of 100,654 shares valued at $0.
CTRV Insider Activity Summary
Who Is Buying CTRV Stock?
No significant insider buying has been recorded for CTRV in the recent period.
Who Is Selling CTRV Stock?
No significant insider selling has been recorded for CTRV in the recent period.
Is ContraVir Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CTRV is bullish with an Insider Alignment Score of 100/100 and a net flow of $34.7K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CTRV Frequently Asked Questions
Understanding CTRV Insider Activity
Insider trading at ContraVir Pharmaceuticals, Inc. (CTRV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading CTRV stock, having executed 17 transactions in the past 90 days. The most active insider is James Sapirstein (Executive), who has made 6 transactions totaling $40.2K.
Related Tools
Track ContraVir Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at CTRV file new Form 4 transactions